Trending Now
Business
General Electric: Are Bulls Prepared For A Dilutive Event?
Last week General Electric (GE) filed a shelf registration that will allow the company to offer senior or subordinated debt securities, preferred stock, common...
Will Weak Guidance Sink Target?
Target (TGT) reports quarterly earnings Tuesday. Analysts expect revenue of $22.53 billion and eps of $1.38. I expect this to be an important earnings...
Lifestyle today
Entertainment
Zooman Miller Describes Confrontation Between Katt Williams And Wanda Smith’s Husband
The fall out from Katt Williams' interview on V103's Frank And Wanda In The Morning continues. Katt Williams went in on Tiffany Haddish and...
Endo: Women Discuss Commercial Appeal For Xiaflex To Treat Cellulite
On February 11th experts discussed Endo International, Xiaflex and Cellulite. The discussion was led by Senator Maria Chappelle-Nadal, Ralph Baker of Shocking The Street...
Has Valeant Run Out Of Catalysts?
Valeant (VRX) bulls continue to promote the stock and deny reality. Management has talked up asset sales and product development, but they have yet...
Pipe Bombs Sent To Barack Obama, Hillary Clinton, CNN
Wednesday pipe bombs were addressed to the home of Barack Obama in Washington, DC and Hillary Clinton in Westchester County NY. The crudely built...
August Jobs Data May Not Prevent Another Rate Cut
The August jobs report reflected showed 130,000 jobs were added, the weakest level of jobs growth:
US job growth slowed to its weakest level in...
GE Could Crater Under Pressure From The PBGC
Last week General Electric (GE) CEO Larry Culp confirmed an urgency to reduce GE's $115 billion debt load through asset sales. The company also...
Trump And The GE: Invanka Trump Claps Back On The Economy
President Trump continues to promote his economic agenda and the strength of the U.S. economy. Unemployment remains in record territory and the Dow Jones...
Allergan, Mohawks Receive IPR Stay For Restasis
Wednesday market chatter suggested a Federal Circuit Court stayed an inter partes review ("IPR") pursuant to patents for Allergan's (AGN) dry eye drug Restasis....
























































































































